Iterum Therapeutics plc (ITRMF)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
-0.0050 (-33.33%)
At close: Apr 29, 2026
Iterum Therapeutics Employees
Iterum Therapeutics had 9 employees as of December 31, 2024. The number of employees decreased by 5 or -35.71% compared to the previous year.
Employees
9
Change (1Y)
-5
Growth (1Y)
-35.71%
Revenue / Employee
$43,333
Profits / Employee
-$2,995,667
Market Cap
792.53K
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| International Stem Cell | 33 |
| Windtree Therapeutics | 14 |
| Evofem Biosciences | 29 |
| Abpro Holdings | 3 |
| LakeShore Biopharma | 573 |
| Lyra Therapeutics | 27 |
| CERo Therapeutics Holdings | 8 |
Iterum Therapeutics News
- 4 weeks ago - Iterum files wind-up petition due to limited cash, inability to raise equity - Reuters
- 4 weeks ago - Iterum Therapeutics Announces Filing of Winding Up Petition - GlobeNewsWire
- 2 months ago - Iterum Therapeutics Provides Business Update - GlobeNewsWire
- 5 months ago - Iterum Therapeutics Earnings Call Transcript: Q3 2025 - Transcripts
- 5 months ago - Iterum Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 6 months ago - Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025 - GlobeNewsWire
- 7 months ago - Iterum Therapeutics to Present Data at IDWeek 2025 - GlobeNewsWire
- 9 months ago - Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S. - GlobeNewsWire